Influence of Body Mass Index on Inflammatory Profile at Admission in Critically Ill Septic Patients
Related Experiment Video
Updated: Apr 10, 2026

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Fernando G Zampieri1, Vanessa Jacob2, Hermes V Barbeiro2
1Medical Investigation Laboratory 51 (LIM-51), Emergency Medicine Discipline, Faculty of Medicine, University of São Paulo, 01246903 São Paulo, SP, Brazil ; Intensive Care Unit, Emergency Medicine Discipline, Hospital das Clínicas, University of São Paulo, 05403-010 São Paulo, SP, Brazil ; Intensive Care Unit, Hospital Alemão Oswaldo Cruz, 01323-020 São Paulo, SP, Brazil.
Abstract:
Introduction. Inflammation is ubiquitous during sepsis and may be influenced by body mass index (BMI). We sought to evaluate if BMI was associated with serum levels of several cytokines measured at intensive care unit admission due to sepsis. Methods. 33 septic patients were included. An array of thirty-two cytokines and chemokines was measured using Milliplex technology. We assessed the association between cytokine levels and BMI by generalized additive model that also included illness severity (measured by SAPS 3 score); one model was built for each cytokine measured. Results. We found that levels of epidermal growth factor, vascular endothelial growth factor, and interleukins 4, 5, and 13 were associated with BMI in a complex, nonlinear way, independently of illness severity. Higher BMI was associated with higher levels of anti-inflammatory interleukins. Conclusion. BMI may influence host response to infection during critical illness. Larger studies should confirm these findings.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Drug Dosing: Obese Patients
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution